🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD.
Register free to view.
Security Profile
- Security Type
- Common Stock
- CUSIP
- 48669G105 (prev. 67010F301 )
- Market Cap
- Micro Cap
- ADR Ratio
- 1:5
- Previous Symbol
- NVGN (changed 11/21/2017)
- Previous Name
- Novogen Ltd
Business: Novogen Ltd is a public Australian biotechnology company. The Company is based in Sydney, Australia and is focused on the development of novel anti-cancer drugs based on two proprietary drug technologies - the super-benzopyran chemical family and anti-tropomyosin drug technology.
Notes: July 14, 2017 -- Novogen Limited (NVGN) will effect a one-for-four (1-4) reverse split of its outstanding American Depositary Shares (“ADS”), and a ratio change of the ADS from one ADS representing twenty-five Ordinary Shares (1:25) to one ADS representing one hundred Ordinary Shares (1:100). The CUSIP number will change to 67010F301.
Company Contact
- CHR
- John Friend
- VPF
- Jeffrey Bonacorda
- Investor Relations
- info@kaziatherapeutics.com